These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35838224)

  • 1. Anthelmintic Drugs for Repurposing against Gram-Negative Bacilli Infections.
    Canturri AM; Smani Y
    Curr Med Chem; 2022; 30(1):59-71. PubMed ID: 35838224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
    Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus.
    Rajamuthiah R; Fuchs BB; Conery AL; Kim W; Jayamani E; Kwon B; Ausubel FM; Mylonakis E
    PLoS One; 2015; 10(4):e0124595. PubMed ID: 25897961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Repurposing for the Treatment of Bacterial and Fungal Infections.
    Miró-Canturri A; Ayerbe-Algaba R; Smani Y
    Front Microbiol; 2019; 10():41. PubMed ID: 30745898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli.
    Domalaon R; Okunnu O; Zhanel GG; Schweizer F
    J Antibiot (Tokyo); 2019 Aug; 72(8):605-616. PubMed ID: 31028351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.
    Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P
    Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
    Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
    Konreddy AK; Rani GU; Lee K; Choi Y
    Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria.
    Peyclit L; Baron SA; Rolain JM
    Front Cell Infect Microbiol; 2019; 9():193. PubMed ID: 31245302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repositioning of non-antibiotic drugs as an alternative to microbial resistance: a systematic review.
    Foletto VS; da Rosa TF; Serafin MB; Bottega A; Hörner R
    Int J Antimicrob Agents; 2021 Sep; 58(3):106380. PubMed ID: 34166776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria.
    Liu Y; Tong Z; Shi J; Li R; Upton M; Wang Z
    Theranostics; 2021; 11(10):4910-4928. PubMed ID: 33754035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bismuth Drugs Reverse Tet(X)-Conferred Tigecycline Resistance in Gram-Negative Bacteria.
    Deng T; Jia Y; Tong Z; Shi J; Wang Z; Liu Y
    Microbiol Spectr; 2022 Feb; 10(1):e0157821. PubMed ID: 35138168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and characterisation of carbapenemase encoding genes in multidrug-resistant Gram-negative bacilli.
    Haji SH; Aka STH; Ali FA
    PLoS One; 2021; 16(11):e0259005. PubMed ID: 34723978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy: the propitious rationale for drug development.
    Phougat N; Khatri S; Singh A; Dangi M; Kumar M; Dabur R; Chhillar AK
    Comb Chem High Throughput Screen; 2014 Jan; 17(1):53-67. PubMed ID: 24138510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico.
    Uc-Cachón AH; Gracida-Osorno C; Luna-Chi IG; Jiménez-Guillermo JG; Molina-Salinas GM
    Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31540314
    [No Abstract]   [Full Text] [Related]  

  • 18. 10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America.
    Boucher HW; Talbot GH; Benjamin DK; Bradley J; Guidos RJ; Jones RN; Murray BE; Bonomo RA; Gilbert D;
    Clin Infect Dis; 2013 Jun; 56(12):1685-94. PubMed ID: 23599308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party.
    Hawkey PM; Warren RE; Livermore DM; McNulty CAM; Enoch DA; Otter JA; Wilson APR
    J Antimicrob Chemother; 2018 Mar; 73(suppl_3):iii2-iii78. PubMed ID: 29514274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections.
    Younis W; Thangamani S; Seleem MN
    Curr Pharm Des; 2015; 21(28):4106-11. PubMed ID: 25961308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.